JAKARTA, Sept 7 (Reuters) - Indonesia has approved the single-dose COVID-19 vaccines produced by Janssen Pharmaceutical Companies, part of Johnson & Johnson, and China's CanSino Biological Inc for emergency use, the country's food and drug agency said in a statement on Tuesday. (Reporting by Stanley Widianto; Writing by Gayatri Suroyo Editing by Ed Davies)
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
21.35 HKD | +0.95% | +16.03% | -9.34% |
04-29 | CanSino Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-22 | Cansino Bio Gets Nod for China Clinical Trials of Haemophilus Influenzae Vaccine | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.34% | 1.17B | |
-3.73% | 87.06B | |
+2.76% | 40.25B | |
-17.49% | 31.09B | |
+54.44% | 24.74B | |
-13.13% | 15.91B | |
-9.12% | 11.96B | |
-15.45% | 11.92B | |
-42.56% | 11.61B | |
+4.87% | 8.73B |
- Stock Market
- Equities
- 6185 Stock
- News CanSino Biologics Inc.
- CanSino Biologics : Indonesia approves J&J, Cansino COVID-19 vaccines for emergency use